IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses

J Immunol. 2009 Jan 1;182(1):225-33. doi: 10.4049/jimmunol.182.1.225.

Abstract

CD8 T cells are necessary for costimulation blockade-resistant rejection. However, the mechanism by which CD8 T cells mediate rejection in the absence of major costimulatory signals is poorly understood. IFN-gamma promotes CD8 T cell-mediated immune responses, but IFN-gamma-deficient mice show early graft loss despite costimulation blockade. In contrast, we found that IFN-gamma receptor knockout mice show dramatically prolonged graft survival under costimulation blockade. To investigate this paradox, we addressed the effects of IFN-gamma on T cell alloresponses in vivo independent of the effects of IFN-gamma on graft survival. We identified a donor-specific CD8 T cell breakthrough response temporally correlated with costimulation blockade-resistant rejection. Neither IFN-gamma receptor knockout recipients nor IFN-gamma-deficient recipients showed a CD8 breakthrough response. Graft death on IFN-gamma-deficient recipients despite costimulation blockade could be explained by the lack of IFN-gamma available to act on the graft. Indeed, the presence of IFN-gamma was necessary for graft survival on IFN-gamma receptor knockout recipients, as either IFN-gamma neutralization or the lack of the IFN-gamma receptor on the graft precipitated early graft loss. Thus, IFN-gamma is required both for the recipient to mount a donor-specific CD8 T cell response under costimulation blockade as well as for the graft to survive after allotransplantation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Abatacept
  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • CD40 Ligand / immunology
  • CD8-Positive T-Lymphocytes / cytology
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • Female
  • Graft Rejection / immunology*
  • Graft Rejection / prevention & control
  • Graft Survival / immunology*
  • Immunoconjugates / administration & dosage
  • Immunosuppressive Agents / administration & dosage
  • Interferon gamma Receptor
  • Interferon-gamma / deficiency
  • Interferon-gamma / genetics
  • Interferon-gamma / physiology*
  • Lymphocyte Activation / immunology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Receptors, Interferon / biosynthesis
  • Receptors, Interferon / deficiency
  • Receptors, Interferon / genetics
  • Skin Transplantation / immunology*
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • Immunoconjugates
  • Immunosuppressive Agents
  • Receptors, Interferon
  • CD40 Ligand
  • Abatacept
  • Interferon-gamma